Perioperative safety of tofacitinib in surgical ulcerative colitis patients-Reference-Cited by-同舟云学术

Perioperative safety of tofacitinib in surgical ulcerative colitis patients

Published:2021-05-24 Issue:8 Volume:23 Page:2085-2090
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Lightner Amy L.¹,Vaidya Prashansha¹,Holubar Stefan¹^ORCID,Warusavitarne Janindra²,Sahnan Kapil²,Carrano Francesco Maria³⁴,Spinelli Antonino⁴,Zaghiyan Karen⁵,Fleshner Phillip R.⁵

Affiliation:

1. Department of Colorectal Surgery Cleveland Clinic Cleveland OH USA

2. Division of Colon and Rectal Surgery St Marks Hospital London UK

3. Division of Colon and Rectal Surgery Humanitas Clinical and Research CenterColon and Rectal Surgery Unit Rozzano Milan Italy

4. Department of Biomedical Sciences Humanitas University Rozzano Milan Italy

5. Division of Colon and Rectal Surgery Cedars‐Sinai Medical Center Los Angeles CA USA

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.15702

Reference46 articles.

1. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

2. Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

3. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

4. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

5. Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis;Journal of the American Academy of Dermatology;2024-08

2. Indikationen zur Unterbrechung von rheumatologischen Basistherapien;rheuma plus;2024-04-26

3. Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study;American Journal of Gastroenterology;2024-03-19

4. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

5. Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review;Diseases of the Colon & Rectum;2024-01-31